Chronic therapy with α1A-adrenergic agonist reverses RV failure and mitochondrial dysfunction
On Yeung Li, Philip M. Swigart, N Reddy, Bat‐Erdene Myagmar, Enkhjin Bat-Erdene, Paul C. Simpson, Anthony J. Baker
This study shows chronic treatment with a 1A-adrenergic agonist improves mitochondrial function and reverses right ventricular failure in a mouse model.
bioRxiv · Mar 20, 2026 · PreprintPhysiology